The Selaginella moellendorffii prescription (SMP) can significantly reduce the level of uric acid in mice with hyperuricemia and reduce the levels of prostaglandin (PG)E-2, IL-8, nitric oxide (NO), and IL-1 in rats with gouty arthritis. Here, IL1B is linked to gout.